Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary intraosseous rhabdomyosarcoma].

F Dujardin1, G Bocquet, M Debled

  • 1Département de Chirurgie Orthopédique et Traumatologique, Hôpital Charles Nicolle, 76031 Rouen Cedex, France. Franck.Dujardin@chu-rouen.fr

Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
|June 9, 2000
PubMed
Summary

This case study details a rare primary intraosseous pleiomorphic rhabdomyosarcoma in a young woman's pelvis. Despite aggressive treatment including hemipelvectomy and amputation, long-term remission was achieved, highlighting the importance of considering primary bone tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced-Stage Hodgkin Lymphoma.

Cancer medicine·2025
Same author

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort.

ESMO open·2025
Same author

Combining Total Metabolic Tumor Volume With Beta-2-Microglobulin Levels Predicts Outcomes in High-Burden Follicular Lymphoma Patients.

Hematological oncology·2024
Same author

Pemigatinib-associated calcinosis cutis: First case of complete regression with continued phosphate chelator therapy.

Annales de dermatologie et de venereologie·2024
Same author

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.

ESMO open·2024
Same author

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.

Scientific reports·2024

Area of Science:

  • Oncology
  • Orthopedic Oncology
  • Skeletal Tumors

Background:

  • Primary intraosseous rhabdomyosarcomas are exceptionally rare.
  • Bone tumors are often metastatic, necessitating careful evaluation to rule out primary origins.

Observation:

  • A 21-year-old woman presented with a lytic pelvic tumor involving the acetabulum and isthmus, with soft tissue extension.
  • Initial chemotherapy failed to halt tumor progression, necessitating radical surgical intervention.

Findings:

  • The patient underwent hemipelvectomy with prosthesis reconstruction, followed by an inter-ilio-abdominal amputation due to septic complications.
  • Recurrence-free remission was achieved for 4 years, supporting the diagnosis of a primary intraosseous tumor.

Implications:

Related Experiment Videos

  • This case underscores the possibility of primary intraosseous rhabdomyosarcoma when no other primary tumor is identified.
  • Radical surgical resection, combined with multidisciplinary management including radiotherapy and chemotherapy, is crucial for improving prognosis in such rare cases.